[Direct mail delivery in about 10 days] This product needs to be purchased after filling out a questionnaire and a simple online consultation to obtain a prescription.
The questionnaire and online consultation take approximately 5 minutes each.
Mounjaro (Tirzepatide) is an innovative drug developed by Eli Lilly and Company.
As a dual receptor agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), it has the dual effects of improving weight management and blood sugar control.
Mounjaro is injected once a week and is suitable for obese or overweight adults, especially those with at least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidemia, etc.).
- Basic Information
-
English name : Tirzepatide
-
Product specification : 2.5mg
- Indications
It is suitable for patients with type 2 diabetes, helping them to effectively control their blood sugar levels and improve abnormal blood sugar metabolism. It has a significant effect on adult type 2 diabetes patients with poor blood sugar control. At the same time, clinical studies have found that some patients can also help with weight management during use, which is good news for type 2 diabetes patients with overweight or obesity problems.
- Dosage
Generally, for adults, the initial dose of telpotide is 2.5 mg once a week, and then the dose is increased to 5 mg once a week for maintenance after 4 weeks of subcutaneous injection. Please strictly follow the doctor's instructions and do not increase or decrease the dose on your own to ensure medication safety and treatment effect.
- Precautions
Before use, please inform your professional doctor in detail of your allergy history, medical history, and other medications you are currently taking to avoid possible drug interactions. If you experience nausea, vomiting, diarrhea, allergies, or other discomfort during medication, stop using the product immediately and seek medical attention.
- Product Advantages
Only one injection is needed per week, which greatly improves the convenience and compliance of patients' medication. It does not require frequent operation and is easier to integrate into daily life. After a large number of clinical verifications, its effectiveness and safety have been fully confirmed, providing reliable protection for patients' health.
Tipoic A 2.5mg provides a scientific and effective treatment option for patients with type 2 diabetes, helping them better manage blood sugar and improve their quality of life.
